0001181431-12-036724.txt : 20120615 0001181431-12-036724.hdr.sgml : 20120615 20120615140058 ACCESSION NUMBER: 0001181431-12-036724 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120615 DATE AS OF CHANGE: 20120615 EFFECTIVENESS DATE: 20120615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-179843 FILM NUMBER: 12909774 BUSINESS ADDRESS: STREET 1: 12085 RESEARCH DRIVE CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 3864184018 MAIL ADDRESS: STREET 1: 12085 RESEARCH DRIVE CITY: ALACHUA STATE: FL ZIP: 32615 D 1 primary_doc.xml X0705 D LIVE 0001174940 ORAGENICS INC 3000 Bayport Drive Suite 685 Tampa FL FLORIDA 33607 (813) 286-7900 FLORIDA ORAGEN, INC None Corporation true JOHN BONFIGLIO 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Executive Officer Director MICHAEL SULLIVAN 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Executive Officer CHRISTINE KOSKI 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Director ROBERT KOSKI 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Director FREDERICK W. TELLING 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Director CHARLES L. POPE 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Director ALAN DUNTON 3000 BAYPORT DRIVE SUITE 685 TAMPA FL FLORIDA 33607 Director Biotechnology $1,000,001 - $5,000,000 06 false 2012-06-05 false true false 0 5798001 5798001 0 The Company issued 4,392,425 common shares to Intrexon Corporation pursuant to an Exclusive Channel Collaboration Agreement. No cash was received. The amount entered is based solely on the closing price of the Company's stock of $1.32 on 6/5/2012. false 1 0 0 0 true ORAGENICS INC /s/ MICHAEL SULLIVAN MICHAEL SULLIVAN CHIEF FINANCIAL OFFICER AND TREASURER 2012-06-15